EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 4,190,921 | $14,668,224 | 8.18% |
Caligan Partners LP | 435,298 | $1,523,543 | 1.27% |
ACUTA CAPITAL PARTNERS, LLC | 303,396 | $1,061,886 | 0.65% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,347,897 | $11,717,640 | 0.49% |
Samsara BioCapital, LLC | 480,000 | $1,680,000 | 0.36% |
RA Capital Management | 3,370,506 | $11,796,771 | 0.24% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 201,810 | $706 | 0.11% |
Legato Capital Management LLC | 76,130 | $266,455 | 0.05% |
BARD ASSOCIATES INC | 30,674 | $107,359 | 0.05% |
LEVIN CAPITAL STRATEGIES, L.P. | 79,000 | $276,500 | 0.04% |